Dr Reddys Laboratories Share Price Today - Live Blog for August 08, 2025

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.27% upswing, and it's currently trading at ₹1,215.00 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd experienced a -0.10% dip in its share price and is currently trading at ₹1,210.15. The stock has a PE ratio of 17.6400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is facing a -0.13% decline and is currently trading at ₹1,210.30 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.21% uptick in its share price. As a result, it's now actively trading at ₹1,212.60 per share, making it an attractive option for investors.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.01% gain, with the share price now at ₹1,210.00. Notably, the stock's PE ratio stands at 17.6400, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd's share price has dropped by -0.05%, a development that warrants careful analysis. Presently trading at ₹1,209.90, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd's share price has dropped by -0.04%, a development that warrants careful analysis. Presently trading at ₹1,210.00, investors are assessing whether this presents an opportunity or a risk.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.21%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,210.50 per share.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.07% upswing, and it's currently trading at ₹1,208.00 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd stock price decreased by -0.22%, with the current market value at ₹1,204.95 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

With a -0.22% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,204.95. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.6400, while the industry PE is 33.3362.

Demonstrating a commendable 0.10% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,207.65. In terms of valuation, the stock maintains a PE ratio of 17.6400, while the industry PE ratio stands at 33.3362.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.12%, reaching the current market price of ₹1,206.40. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's share price rallied by 0.09%, reaching the current market price of ₹1,205.05. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's stock has surged by 0.09%, and it is currently trading at ₹1,205.05. Additionally, the stock maintains a PE ratio of 17.6400, while the industry PE is 33.3362.

The share price of Dr Reddys Laboratories Ltd plunged by -0.03%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,204.00, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.18% recently. As of now, this stock is actively trading at a current market price of ₹1,204.10 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd's stock price surged by 0.16%, reaching the current market value of ₹1,201.90 per share. This surge is a testament to the stock's recent performance.

There were no alterations in the share price of Dr Reddys Laboratories Ltd, and it is currently trading at ₹1,200.00. The stock has a PE ratio of 17.6400, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.06%, and it's currently trading at ₹1,197.50. The stock maintains a PE of 17.6400, while the industry PE is 33.3362, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd suffered a -0.13% drop, and it's now trading at ₹1,197.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd shares saw a -0.10% decrease, reaching a current market price of ₹1,199.85. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.6400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a notable 0.04% surge in its share price and is presently trading at ₹1,201.00, captivating the attention of market participants.

Dr Reddys Laboratories Ltd's share price has dropped by -0.15%, a development that warrants careful analysis. Presently trading at ₹1,200.55, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.23%, reaching a current market price of ₹1,202.20. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The share price of Dr Reddys Laboratories Ltd experienced a -0.23% slump and is currently trading at ₹1,202.20. While the stock maintains a PE ratio of 17.6400, the industry PE is 33.3362, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price has fallen by -0.43%, a situation worth noting. At present, the stock is trading at ₹1,203.80. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.6400, while the industry PE ratio is 33.3362.